re: sirtex us media coverage valuation
getting a few again on bid again as long as it lasts. Onwards and upwards when hits Asx.Ist comes all 6 positive trial results, then major licencing deal, then huge earnings ,then disclosing acquistion offers. The sequences of disclosing news serves purpose of getting sp near $6, by then can disclose acquistion at a premium. Over the last few years since the rejected Cephalon bid, Dr Gray can get the deal done at avery nice premium to previous bid.
SRX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held